Nadeem Ghali
About Nadeem Ghali
Nadeem Ghali is the VP Global Medical Affairs (Ex Greater China) Solid Tumor Lead at BeiGene, with over 20 years of experience in oncology within the pharmaceutical and biotechnology industries.
Current Role at BeiGene
Nadeem Ghali is currently serving as the Vice President of Global Medical Affairs (Ex Greater China) and Solid Tumor Lead at BeiGene. In this capacity, he oversees the global medical strategies and initiatives for solid tumor oncology, excluding the Greater China region. His responsibilities include leading medical affairs teams and collaborating with cross-functional teams to drive the success of oncology products within the company's portfolio.
Previous Experience at Incyte
Before joining BeiGene, Nadeem Ghali worked at Incyte as the Senior Director of Oncology Global Medical Affairs Lead from 2018 to 2022. During his four-year tenure at Incyte, he played a pivotal role in guiding the global medical affairs strategies for oncology products. His leadership contributed to the successful execution of medical programs and collaboration with internal and external stakeholders in the oncology field.
Professional Background in Oncology Medical Affairs
Nadeem Ghali has over two decades of experience in the pharmaceutical and biotechnology industries, with a strong focus on oncology. His career includes significant roles at top-tier companies such as Genentech, sanofi-aventis, and Roche. At Genentech, he served in various capacities, including Medical Science Director and Oncology Medical Science Liaison. He also held leadership positions at NanoString Technologies, Inc. and sanofi-aventis, where he directed global oncology medical affairs strategies.
Educational Background
Nadeem Ghali holds a Doctor of Pharmacy (Pharm.D.) degree from Northeastern University, where he studied from 1995 to 2001. His education laid the foundational knowledge in pharmacy and clinical sciences, which he leveraged throughout his career in medical affairs and oncology.
Contributions to Oncology Research and Collaboration
Throughout his career, Nadeem Ghali has significantly contributed to the field of oncology through the development and implementation of medical strategies for various oncology products. He has collaborated with cross-functional teams, including clinical development, regulatory affairs, and commercial teams, ensuring a cohesive approach to cancer treatment. Additionally, he has been involved in the publication and dissemination of oncology research, enhancing the scientific community's understanding of cancer treatment.